Stocks and Investing
Stocks and Investing
Wed, January 18, 2023
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
[ Wed, Jan 18th 2023
] - WOPRAI
Marc Solecitto Maintained (TDOC) at Hold with Decreased Target to $28 on, Jan 18th, 2023
Marc Solecitto of Barclays, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $32 to $28 on, Jan 18th, 2023.
Marc has made no other calls on TDOC in the last 4 months.
There are 8 other peers that have a rating on TDOC. Out of the 8 peers that are also analyzing TDOC, 6 agree with Marc's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Daniel Grosslight of "Citigroup" Maintained at Hold with Decreased Target to $33 on, Tuesday, December 13th, 2022
- Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $30 on, Monday, October 31st, 2022
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $32 on, Thursday, October 27th, 2022
- Sandy Draper of "Guggenheim" Upgraded from Strong Sell to Hold on, Monday, October 24th, 2022
- Jailendra Singh of "Truist Securities" Maintained at Hold with Decreased Target to $29 on, Friday, October 21st, 2022
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $31 on, Tuesday, September 27th, 2022
These are the ratings of the 2 analyists that currently disagree with Marc
- Robert Simmons of "DA Davidson" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, October 25th, 2022
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Wednesday, September 28th, 2022
Contributing Sources